Brief: Standard Biotools Upon Termination Of Deal, Co May Be Required To Pay Somalogic Fee Of $19.1 Million And/Or Reimburse Somalogic's Expenses Up To $2 Million
Oct 4 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS: UPON TERMINATION OF DEAL, CO MAY BE
REQUIRED
TO PAY SOMALOGIC FEE OF $19.1 MILLION AND/OR REIMBURSE
SOMALOGIC'S EXPENSES UP TO $2 MILLION
* STANDARD BIOTOOLS: UPON TERMINATION OF DEAL BY SOMALOGIC,
SOMALOGIC MAY REQUIRED TO PAY CO FEE OF $17.2 MILLION AND/OR
REIMBURSE EXPENSES UP TO OF $2 MILLION
Source text for Eikon: ID:
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07